Nkarta, Inc. (NKTX)
2.92
+0.13
(+4.66%)
USD |
NASDAQ |
Sep 04, 16:00
2.91
-0.01
(-0.34%)
Pre-Market: 20:00
Nkarta SG&A Expense (TTM) : 32.74M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.74M |
| March 31, 2026 | 25.06M |
| December 31, 2025 | 31.57M |
| September 30, 2025 | 33.68M |
| June 30, 2025 | 35.14M |
| March 31, 2025 | 36.32M |
| December 31, 2024 | 31.45M |
| September 30, 2024 | 31.52M |
| June 30, 2024 | 30.07M |
| March 31, 2024 | 34.22M |
| December 31, 2023 | 34.88M |
| September 30, 2023 | 35.15M |
| June 30, 2023 | 34.88M |
| March 31, 2023 | 29.71M |
| December 31, 2022 | 28.06M |
| Date | Value |
|---|---|
| September 30, 2022 | 25.51M |
| June 30, 2022 | 24.49M |
| March 31, 2022 | 23.60M |
| December 31, 2021 | 23.02M |
| September 30, 2021 | 24.16M |
| June 30, 2021 | 22.26M |
| March 31, 2021 | 19.08M |
| December 31, 2020 | 15.29M |
| September 30, 2020 | 10.53M |
| June 30, 2020 | 7.897M |
| March 31, 2020 | 6.456M |
| December 31, 2019 | 5.247M |
| September 30, 2019 | 3.281M |
| June 30, 2019 | 1.992M |
| March 31, 2019 | 0.9398M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Theriva Biologics, Inc. | 6.919M |
| Yarrow Bioscience, Inc. | 10.57M |
| Unicycive Therapeutics, Inc. | 23.53M |
| OnKure Therapeutics, Inc. | 15.19M |